Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
10.09
+0.01 (0.10%)
At close: Aug 14, 2026, 4:00 PM EDT
10.29
+0.20 (1.98%)
After-hours: Aug 14, 2026, 7:59 PM EDT
CRBP Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, CRBP stock has a consensus rating of "Strong Buy" and an average price target of $34.53. The average 1-year stock price forecast is 242.22% higher than the current stock price, while the lowest is $17.25 (+70.96%) and the highest is $48 (+375.72%).
Price Target: $34.53 (+242.22%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CRBP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 9 | 9 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $34 → $33 | Buy | Maintains | $34 → $33 | +227.06% | Aug 12, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $36 | Buy | Maintains | $36 | +256.79% | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $38 | Buy | Maintains | $38 | +276.61% | Aug 7, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $52 → $48 | Buy | Reiterates | $52 → $48 | +375.72% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 → $35 | Buy | Reiterates | $40 → $35 | +246.88% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
1.25M
Revenue Next Year
2.40M
from 1.25M
Increased by 92.00%
EPS This Year
-5.43
from -5.90
EPS Next Year
-5.51
from -5.43
EPS and Forward PE are based on non-GAAP adjusted numbers.